Stifel analyst Parker Lane maintains Guidewire Software (NYSE:GWRE) with a Hold and lowers the price target from $110 to $100.
Mizuho Maintains Buy on AbbVie, Raises Price Target to $166
Mizuho analyst Vamil Divan maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $154 to $166.